195 related articles for article (PubMed ID: 23373973)
1. Effect of miR-122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis.
Iino I; Kikuchi H; Miyazaki S; Hiramatsu Y; Ohta M; Kamiya K; Kusama Y; Baba S; Setou M; Konno H
Cancer Sci; 2013 May; 104(5):624-30. PubMed ID: 23373973
[TBL] [Abstract][Full Text] [Related]
2. Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis.
Murakami T; Kikuchi H; Ishimatsu H; Iino I; Hirotsu A; Matsumoto T; Ozaki Y; Kawabata T; Hiramatsu Y; Ohta M; Kamiya K; Fukushima M; Baba S; Kitagawa K; Kitagawa M; Konno H
Br J Cancer; 2017 Oct; 117(9):1360-1370. PubMed ID: 29065427
[TBL] [Abstract][Full Text] [Related]
3. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of mir-10b predicate advanced clinicopathological features and liver metastasis in colorectal cancer.
Jiang H; Liu J; Chen Y; Ma C; Li B; Hao T
Cancer Med; 2016 Oct; 5(10):2932-2941. PubMed ID: 27592860
[TBL] [Abstract][Full Text] [Related]
5. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
6. MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.
Miyoshi J; Toden S; Yoshida K; Toiyama Y; Alberts SR; Kusunoki M; Sinicrope FA; Goel A
Sci Rep; 2017 Mar; 7():43393. PubMed ID: 28262692
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-17 is correlated with liver metastasis in colorectal cancer.
Lai H; Zhang J; Zuo H; Liu H; Xu J; Feng Y; Lin Y; Mo X
Medicine (Baltimore); 2020 Feb; 99(9):e19265. PubMed ID: 32118734
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR‑221 and miR‑222 in the cancer stroma is associated with malignant potential in colorectal cancer.
Iida M; Hazama S; Tsunedomi R; Tanaka H; Takenouchi H; Kanekiyo S; Tokumitsu Y; Tomochika S; Tokuhisa Y; Sakamoto K; Suzuki N; Takeda S; Ueno T; Yamamoto S; Yoshino S; Fujita K; Kuroda M; Nagano H
Oncol Rep; 2018 Sep; 40(3):1621-1631. PubMed ID: 30015977
[TBL] [Abstract][Full Text] [Related]
9. microRNA-320a inhibits tumor invasion by targeting neuropilin 1 and is associated with liver metastasis in colorectal cancer.
Zhang Y; He X; Liu Y; Ye Y; Zhang H; He P; Zhang Q; Dong L; Liu Y; Dong J
Oncol Rep; 2012 Mar; 27(3):685-94. PubMed ID: 22134529
[TBL] [Abstract][Full Text] [Related]
10. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
Feiersinger F; Nolte E; Wach S; Rau TT; Vassos N; Geppert C; Konrad A; Merkel S; Taubert H; Stürzl M; Croner RS
PLoS One; 2016; 11(2):e0148580. PubMed ID: 26845148
[TBL] [Abstract][Full Text] [Related]
12. Differential microRNA expression profiling in primary tumors and matched liver metastasis of patients with colorectal cancer.
Li W; Chang J; Tong D; Peng J; Huang D; Guo W; Zhang W; Li J
Oncotarget; 2017 May; 8(22):35783-35791. PubMed ID: 28415758
[TBL] [Abstract][Full Text] [Related]
13. Association of differential miRNA expression with hepatic vs. peritoneal metastatic spread in colorectal cancer.
Heublein S; Albertsmeier M; Pfeifer D; Loehrs L; Bazhin AV; Kirchner T; Werner J; Neumann J; Angele MK
BMC Cancer; 2018 Feb; 18(1):201. PubMed ID: 29463215
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
15. Down-Regulation of microRNA-132 is Associated with Poor Prognosis of Colorectal Cancer.
Mokutani Y; Uemura M; Munakata K; Okuzaki D; Haraguchi N; Takahashi H; Nishimura J; Hata T; Murata K; Takemasa I; Mizushima T; Doki Y; Mori M; Yamamoto H
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):599-608. PubMed ID: 26868958
[TBL] [Abstract][Full Text] [Related]
16. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis.
Wang LG; Gu J
Cancer Epidemiol; 2012 Feb; 36(1):e61-7. PubMed ID: 22018950
[TBL] [Abstract][Full Text] [Related]
17. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
19. miR-146a targets c-met and abolishes colorectal cancer liver metastasis.
Bleau AM; Redrado M; Nistal-Villan E; Villalba M; Exposito F; Redin E; de Aberasturi AL; Larzabal L; Freire J; Gomez-Roman J; Calvo A
Cancer Lett; 2018 Feb; 414():257-267. PubMed ID: 29133238
[TBL] [Abstract][Full Text] [Related]
20. Decreased miR-340 expression in bone marrow is associated with liver metastasis of colorectal cancer.
Takeyama H; Yamamoto H; Yamashita S; Wu X; Takahashi H; Nishimura J; Haraguchi N; Miyake Y; Suzuki R; Murata K; Ohue M; Kato T; Takemasa I; Mizushima T; Ishii H; Mimori K; Doki Y; Mori M
Mol Cancer Ther; 2014 Apr; 13(4):976-85. PubMed ID: 24448820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
